CA 549 and SP2: new tumor markers in breast cancer.
Torres
M
M
Jiménez-Heffernan
A
A
García
A
A
Valverde
A
A
Mateo
A
A
D000911:Antibodies, Monoclonal / Q000276:immunology; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002352:Carrier Proteins; D005260:Female; D006023:Glycoproteins; D006801:Humans; D008074:Lipoproteins; D009363:Neoplasm Proteins / Q000097:blood*; D010455:Peptides / Q000097:blood; D011237:Predictive Value of Tests; D019396:Tissue Polypeptide Antigen; D016326:Extracellular Matrix Proteins
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D002352:Carrier Proteins; D006023:Glycoproteins; D008074:Lipoproteins; D009363:Neoplasm Proteins; D010455:Peptides; D019396:Tissue Polypeptide Antigen; C081856:LGALS3BP protein, human; D016326:Extracellular Matrix Proteins